Ann Lab Med.  2021 Mar;41(2):255-257. 10.3343/alm.2021.41.2.255.

Development of Crohn’s Disease in a Child With SLC26A3-related Congenital Chloride Diarrhea: Report of the First Case in East Asia and a Novel Missense Variant

• Kim ES
• Song JS
• Ki CS
• Choe YH
• Kang B

• KMID: 2512676
• DOI: http://doi.org/10.3343/alm.2021.41.2.255

Figure

• 

  Fig. 1 Diagnosis of congenital chloride diarrhea and Crohn’s disease. (A) Sanger sequencing of the SLC26A3 gene in the patient and his parents. (B) Ileocolonoscopy at the diagnosis of Crohn’s disease.

Reference

1. Wedenoja S, Pekansaari E, Höglund P, Mäkelä S, Holmberg C, Kere J. 2011; Update on SLC26A3 mutations in congenital chloride diarrhea. Hum Mutat. 32:715–22. DOI: 10.1002/humu.21498. PMID: 21394828.

2. Hihnala S, Höglund P, Lammi L, Kokkonen J, Ormälä T, Holmberg C. 2006; Long-term clinical outcome in patients with congenital chloride diarrhea. J Pediatr Gastroenterol Nutr. 42:369–75. DOI: 10.1097/01.mpg.0000214161.37574.9a. PMID: 16641574.

3. Harris RE, Tayler R, Russell RK. Congenital chloride-losing diarrhoea and Crohn's disease: a diagnostic and therapeutic challenge. Frontline Gastroenterology. Epub ahead of print. doi:10.1136/flgastro-2019-101283. DOI: 10.1136/flgastro-2019-101283.

4. Norsa L, Pigneur B, Goulet O, Talbotec C, Lengline H, Rummele F. 2016; Potential association between congenital chloride diarrhea and inflammatory bowel disease. Dig Liver Dis. 48:e268. DOI: 10.1016/j.dld.2016.08.074.

5. Hong J, Seo JK, Ko JS, Cheong HI, Choi JH, Lee JH, et al. 2013; Congenital chloride diarrhea in Korean children: novel mutations and genetic characteristics. Eur J Pediatr. 172:545–50. DOI: 10.1007/s00431-012-1905-3. PMID: 23274434.

6. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. 2015; Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 17:405–24. DOI: 10.1038/gim.2015.30. PMID: 25741868. PMCID: PMC4544753.

7. Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. 2011; Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 17:1314–21. DOI: 10.1002/ibd.21493. PMID: 21560194.

8. Xiao F, Yu Q, Li J, Johansson ME, Singh AK, Xia W, et al. 2014; Slc26a3 deficiency is associated with loss of colonic HCO3secretion, absence of a firm mucus layer and barrier impairment in mice. Acta Physiol (Oxf). 211:161–75. DOI: 10.1111/apha.12220. PMID: 24373192.

9. Yang H, Jiang W, Furth EE, Wen X, Katz JP, Sellon RK, et al. 1998; Intestinal inflammation reduces expression of DRA, a transporter responsible for congenital chloride diarrhea. Am J Physiol. 275:G1445–53. DOI: 10.1152/ajpgi.1998.275.6.G1445. PMID: 9843783.

10. Ding X, Li D, Li M, Tian D, Yu H, Yu Q. 2018; Tumor necrosis factor-α acts reciprocally with solute carrier family 26, member 3, (downregulated-in-adenoma) and reduces its expression, leading to intestinal inflammation. Int J Mol Med. 41:1224–32. DOI: 10.3892/ijmm.2017.3347. PMID: 29286110. PMCID: PMC5819926.